Merger Arbitrage Mondays – Big Pharma Spends $5 Billion On Acquisitions

Merger activity decreased with four new deals announced and two deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.

There were two new deals announced in the Deals in the Works section.

Deal Statistics:

New Deals:

1. The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $891.47 million or $4.00 per share in cash.
2. The acquisition of Synthorx (THOR) by Sanofi for $2.35 billion or $68.00 per share in cash.
3. The acquisition of ArQule (ARQL) by Merck & Co. (MRK) for $2.5 billion or $20.00 per share in cash.

Only plus or premium subscribers can access this post. Subscribe today.